The Lustgarten Equity, Accessibility, and Diversity (LEAD) Project aims to increase recruitment and retention of underrepresented groups in pancreatic cancer clinical trials by supporting institutions that make intentional efforts to address barriers to participation among underrepresented groups and develop and implement specific tools to increase clinical trial participation. Support for the LEAD grant is made possible, in part, by a donation from Northwell Health Cancer Institute.

The LEAD Project will support programs with specific, achievable, and measurable goals for increasing the recruitment and retention of patients from underrepresented minority groups in pancreatic cancer clinical trials. This call is intended to support programs that will address specific barriers to participation in clinical trials and can include efforts to expand community outreach, patient education and/or clinical recruitment staff. It is not intended for the development of new clinical trials. Proposals should come from centers that see a high volume of pancreatic cancer cases, are currently running clinical trials in pancreatic cancer, and seek to increase the participation of patients from underrepresented groups in clinical trials. We welcome collaboration with centers to meet the criteria. Proposals that engage community hospitals and other community providers are encouraged.

Read more about this program and apply